People that are currently receiving medication which are strong inducers or inhibitors of CYP3A4 are usually not qualified. Powerful inducers or inhibitors of CYP3A4 should be averted from fourteen times previous to enrollment to the end with the study. Experimental: Dose expansion_sub-populace 2_higher dose of niraparib MTDs and/or applicant RP2Ds https://bobg444tfp7.levitra-wiki.com/user